HealthPrime Medicine Shares Hit 52-Week High After Dosing Begins in PM577a Trial
By Chris Wack Prime Medicine shares rose after the company said the first patient has been dosed in a Phase 1/2 clinical trial of PM577a, an investigational in vivo …
NY Daily Wire
HealthBy Chris Wack Prime Medicine shares rose after the company said the first patient has been dosed in a Phase 1/2 clinical trial of PM577a, an investigational in vivo …